Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-α-stimulated human hepatic stellate cells
- 18 April 2006
- journal article
- Published by Elsevier in Life Sciences
- Vol. 78 (21) , 2510-2515
- https://doi.org/10.1016/j.lfs.2005.10.003
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Glucocorticoid-Mediated Suppression of Cytokine-Induced Matrix Metalloproteinase-9 Expression in Rat Mesangial Cells: Involvement of Nuclear Factor-κB and Ets Transcription FactorsMolecular Endocrinology, 2002
- Chronic liver injury, TGF-β, and cancerExperimental & Molecular Medicine, 2001
- Hepatic Stellate Cells as a Target for the Treatment of Liver FibrosisSeminars in Liver Disease, 2001
- FK506, An Immunosuppressant Targeting Calcineurin FunctionCurrent Medicinal Chemistry, 2000
- Cytokine regulation of liver injury and repairImmunological Reviews, 2000
- New aspects of hepatic fibrosisJournal of Hepatology, 2000
- Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κBFEBS Letters, 1998
- Mechanisms Controlling the Transcription of Matrix Metalloproteinase Genes in Normal and Neoplastic CellsEnzyme and Protein, 1996
- Identification of calcineurin as a key signalling enzyme in T-lymphocyte activationNature, 1992
- Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.Journal of Clinical Investigation, 1989